Clinical Trial Update: Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating doxorubicin hydrochloride liposome as first-line therapy in older women with metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOXORUBICIN HYDROCHLORIDE LIPOSOME (DOXORUBICIN HYDROCHLORIDE)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED